 5AM Venture Management LLC lessened its position in shares of Crinetics Pharmaceuticals Inc NASDAQ:CRNX by 21.2 in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission SEC. The institutional investor owned 1,862,286 shares of the companys stock after selling 500,000 shares during the quarter. Crinetics Pharmaceuticals comprises 8.5 ... 